학술논문
Tifcemalimab combined with toripalimab and chemotherapy as 1st line treatment for extensive-stage small cell lung cancer (ES-SCLC): A phase Ib/II, open-label study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755